Clearside Biomedical, Inc.CLSD
...Loading CLSD Peers...
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
30 Employees
CEO : Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Address : 900 North Point Parkway, Alpharetta,GA, US, - 30005,
| Key Excutives | Designation |
|---|---|
| Mr. Rafael V. Andino | Senior Vice President of Engineering & Manufacturing |
| Mr. Leslie B. Zacks | Secretary |
| Dr. Ngai Hang Chong FRCOphth, FRCS, M.B.A., M.D. | Chief Medical Officer |
| Ms. Jenny R. Kobin | Head of Investor Relations |
| Mr. Rick McElheny | Senior Vice President of Corporate Development & Alliance Management |
| Ms. Susan L. Coultas Ph.D. | Chief Clinical Officer |
| Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D. | President, Chief Executive Officer & Director |
| Mr. Charles A. Deignan | Chief Financial Officer |